GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (CHIX:ERFp) » Definitions » Debt-to-Revenue

Eurofins Scientific SE (CHIX:ERFP) Debt-to-Revenue : 0.52 (As of Jun. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Eurofins Scientific SE Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Eurofins Scientific SE's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €171 Mil. Eurofins Scientific SE's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €3,374 Mil. Eurofins Scientific SE's annualized Revenue for the quarter that ended in Jun. 2024 was €6,837 Mil. Eurofins Scientific SE's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 was 0.52.


Eurofins Scientific SE Debt-to-Revenue Historical Data

The historical data trend for Eurofins Scientific SE's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Debt-to-Revenue Chart

Eurofins Scientific SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.78 0.58 0.41 0.50 0.60

Eurofins Scientific SE Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.50 0.51 0.59 0.52

Competitive Comparison of Eurofins Scientific SE's Debt-to-Revenue

For the Diagnostics & Research subindustry, Eurofins Scientific SE's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eurofins Scientific SE's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Eurofins Scientific SE's Debt-to-Revenue falls into.



Eurofins Scientific SE Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Eurofins Scientific SE's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(601 + 3325.5) / 6514.6
=0.60

Eurofins Scientific SE's annualized Debt-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(170.7 + 3373.5) / 6837.4
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2024) Revenue data.


Eurofins Scientific SE Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Eurofins Scientific SE's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Eurofins Scientific SE Business Description

Address
23 Val Fleuri, Luxembourg, LUX, L-1526
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its areas of business activity are food, feed, and environmental testing ("Life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.

Eurofins Scientific SE Headlines

No Headlines